ClinicalTrials.gg
RecruitingNCT07264127Updated Apr 22, 2026

Clinical Performance of the I-arch System During the Initial Stage of Orthodontic Treatment

An interventional study of The use of 0.016×0.014 copper nickel titanium arch wire during the alignment stage. and Use of 0.014- then 0.016-inch heat-activated nickel titanium arch wire during the alignment stage. in Effectiveness of the I-arch System, sponsored by Tabark H. Omran. Recruiting at 1 site in Iraq. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Tabark H. Omran · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Dec 2025; still recruiting 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if the I-arch system works to align the moderately misaligned teeth in patients seeking orthodontic treatment. it aims to answer the following questions:

  • Does I-arch system increase the rate of teeth alignment?
  • Does I-arch system produce significant changes in arch width and incisors inclination?
  • Does I-arch system decrease the intensity of patient-reported pain and root resorption? Researchers will compare the effectiveness of the I-arch and MBT arch wire system.
Read the detailed description

This study will be a multicenter non-stratified prospective randomized clinical trial designed as a blinded, parallel group trial with equal randomization (1:1 allocation ratio). It will be conducted at multiple orthodontic centers. Initially, the eligibility of the patients to participate in this study will be evaluated by the investigator. Verbal information about the nature of study will be supplied for those who will satisfy the inclusion criteria to obtain their preliminary approval. Then the patient information sheet and consent form will be given to the patients to read carefully at home to decide whether they will participate in the study at the following visit. Patient assent/parental consent will be taken for participants below 18 years. If the patients have any queries regarding the study, the investigator should resolve it on the following visit.

Orthodontic treatment will be conducted using a straight wire appliance. MBT prescription brackets with 0.018-inch slot (Microfit™, SIA Orthodontic Manufacturer, Italy) will be used. With the aid of a height gauge, standardized bracket placement will be achieved. The technique will begin with a 10-second prophylactic procedure to clean and polish the teeth surfaces with pumice and a rubber cup using a slow-speed handpiece. Then, teeth will be rinsed with water and dried with oil-free air spray for 30 seconds. For the purpose of standardization, bonding procedure will be as followed:

  • The enamel surface will be etched with 37% phosphoric acid gel for 30 seconds.
  • The acid etchant will be rinsed off with water spray thoroughly.
  • The tooth surface will be dried by air spray until the white frosty appearance of the etched surface is seen.
  • A thin layer of Light Bond™ Sealant (Reliance®, Itasca, USA) will be applied on the etched enamel surface for one minute, then air will be applied for 5 seconds.
  • Brackets and tubes will be bonded using Light Bond™ light cure orthodontic adhesive (Reliance®, Itasca, USA) which applied on their bases and light-cured above interproximal contacts at a distance of 2-3 mm (5 seconds mesially and 5 seconds distally for brackets and 10 seconds mesially and 10 seconds occlusally for molar tubes).

Arch wire sequence for each group will be as follows:

  1. I-arch system group (I-arch™ Orthodontic System, SIA Orthodontic Manufacturer, Italy. (

    • 0.016×0.014-inch copper nickel titanium.
  2. MBT arch wire system group (Thermal NiTi™, SIA Orthodontic Manufacturer, Italy)

    • 0.014-inch heat-activated nickel titanium.
    • 0.016-inch heat-activated nickel titanium. A standardized protocol will be followed during the treatment for all the participants. At the day of bonding, 0.016×0.014 copper nickel titanium arch wire will be placed for the I-arch group and religated every four weeks. While, for the MBT group, 0.014-inch heat-activated nickel titanium arch wire will be placed at the day of bonding, then after 8 weeks it will be replaced by the 0.016-inch heat-activated nickel titanium arch wire for another 8 weeks (both will be religated every four weeks). Elastomeric modules will be used for ligating the wire to the brackets. If any bracket debonding occurs throughout the course of the treatment, it should be bonded again during 24 hours. Otherwise, the participant will be excluded from the trial. Since this study will be performed during the initial phase of treatment, no deviation from the protocol of treatment will be accepted (such as adding additional arch wire in the sequence or using power chain). Digital scan for the maxillary and mandibular arches will be taken pre-treatment and after 4, 8, 12 and 16 weeks, and a digital model will be obtained which will be used to measure Little's irregularity index, the intercanine and intermolar widths. Lateral cephalometric radiograph and periapical radiographs (for the maxillary and mandibular central incisors) will be taken pre-treatment and after 16 weeks. Lateral cephalometric radiographs will be used to measure the inclination of the maxillary and mandibular incisors. While the periapical radiographs will be used to assess the root resorption of the maxillary and mandibular central incisors. The participants will be supplied with a visual analog scale (0-10) to record their pain perception during the first seven days following the first wire placement. At the end of the trial, the treatment will continue as prescribed.
02

Conditions studied

  • Effectiveness of the I-arch System

Browse trials for

Keywords

  • Archwire
  • Teeth alignment
  • Crowding
  • Orthodontics
  • Clinical trial
  • I-arch
03

In context

Crowding

88 studies on the registry are indexed under Crowding; 22 are open to participants now.

This study's planned enrollment of 34 is close to the median of 36 across 74 interventional studies indexed under Crowding.

Browse Crowding studies →

Lead sponsor

This is the only study on the registry with Tabark H. Omran as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Moderate crowding of mandibular anterior teeth (3-6 mm) according to Little's irregularity index (LII) in patients with age of 12 years or older.
  2. Full complement of permanent dentition should be present, except for the third molars.
  3. Brackets should be placed on maxillary and mandibular anterior teeth without any interference by the existing overbite and overjet.
  4. The maxillary and mandibular incisors should not be previously subjected to trauma or root resorption.

Exclusion criteria

Exclusion Criteria:

  1. Patients with history of previous orthodontic treatment.
  2. Severe maxillary and mandibular anterior crowding which is greater than 6 mm (LII).
  3. Presence of teeth that are severely misaligned out of the dental arch and cannot be engaged with the aligning arch wire.
  4. Prescence of periodontally compromised teeth and previous loss of attachment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
34 participants (estimated)

Study arms

  • Experimental
    Arm 1: I-arch system

    Intervention: Use of 0.016×0.014-inch copper nickel titanium arch wire during the alignment stage.

    Device: The use of 0.016×0.014 copper nickel titanium arch wire during the alignment stage.

  • Active comparator
    Arm 2: MBT arch wire system

    Intervention: Use of 0.014- then 0.016-inch heat-activated nickel titanium arch wire during the alignment stage.

    Device: Use of 0.014- then 0.016-inch heat-activated nickel titanium arch wire during the alignment stage.

Interventions

  • DeviceThe use of 0.016×0.014 copper nickel titanium arch wire during the alignment stage.

    Teeth alignment using an initial arch wire with a rectangular switched cross-section since the beginning of the treatment.

  • DeviceUse of 0.014- then 0.016-inch heat-activated nickel titanium arch wire during the alignment stage.

    Teeth alignment using initial arch wires with round cross sections.

06

What researchers measure

Primary outcomes

  1. The rate of alignment

    Alignment rate will be measured using Little's Irregularity Index on digital dental models. This index range between 0 to 10. "0" indicates perfect alignment, while "10" indicates very severe irregularities.

    Time frame: 16 weeks

Secondary outcomes

  1. The amount of inclination of the incisors

    Maxillary and mandibular incisors inclination will be measured on lateral cephalometric radiographs.

    Time frame: 16 weeks

  2. The change in the width of dental arches

    Maxillary and mandibular intermolar and intercanine widths will be measured on digital dental models.

    Time frame: 16 weeks

  3. The amount of root resorption

    the root resorption of the maxillary and mandibular central incisors will be assessed on periapical radiographs using the long cone paralleling technique. The root resorption will be measured according to Malmgren Index. this index range between 0 to 4. "0" indicates no resorption, while "4" indicates the resorption of more than one-third of the root length.

    Time frame: 16 weeks

  4. The intensity of pain

    Pain intensity will be measured using visual analog scale. The minimum value is zero, while the maximum one is 10. The highest pain intensity is reported as 10.

    Time frame: Throughout the seven days following the insertion of the first arch wire

07

Study locations

1 of 1 sites recruiting
  • AlHur ALriyahi and Hai Alhussein specialized dental centerS
    Karbala, Iraq
    Recruiting
    • Tabark Omran, postgraduate student · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — For the purpose of maintaining the confidentiality of the participants and the associated restrictions imposed by the ethics committee, we choose not to share IPD. However, IPD can be shared with journal editor upon request during the study publication.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07264127
Lead sponsor
Tabark H. Omran
Responsible party
Tabark H. Omran (Principal investigator, University of Baghdad) — Sponsor-investigator
First posted
Dec 4, 2025
Start date
Dec 1, 2025
Primary completion
Jul 1, 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Apr 22, 2026

Study contacts

Tabark H. Omran
Contact
tabarkhaleem9@gmail.com
B.D.S ext. +9647711387246
Prof. dr. Yassir A. Yassir, PhD
Contact
yassirkyassir@gmail.com
Yassir Yassir, PhD
study director · College of dentistry/ Baghdad university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion